Dr. Rakiva is the Director of the Pharmaceutical and Biomedical Team at Global IP Partners. A qualified medical doctor with extensive expertise in pharmaceuticals, biomedical sciences, and intellectual property, she brings a unique blend of clinical insight and IP strategy to support clients worldwide.

Her role involves providing strategic guidance and leadership across projects involving Patent Analytics, Freedom-to-Operate (FTO) Studies, Infringement and Invalidity Analyses, Patent Drafting, Opposition Searches, and IP Due Diligence in the pharmaceutical and biomedical domains. Leveraging her deep knowledge of medical and pharmaceutical practices, Dr. Rakiva helps clients navigate complex patent landscapes and make informed decisions that accelerate research, development, and commercialization.

She has partnered with pharmaceutical companies, R&D institutes, biomedical firms, and IP law practices, assisting them in protecting innovation, mitigating risks, and identifying opportunities in highly competitive markets. Her expertise extends to areas such as small molecules, vaccines, biologics, biosimilars, cell and gene therapy, diagnostics, and personalised medicine.

With her ability to bridge complex scientific concepts and legal frameworks, Dr. Rakiva ensures that innovative treatments and healthcare technologies are not only developed but also secured through strong IP protection. Her leadership, client-focused approach, and dedication to advancing the pharmaceutical and biomedical sectors make her a trusted advisor to IP professionals and industry leaders alike.